Antibiotic-resistant staphylococci are the leading cause of nosocomial infections in many
hospitals around the world. Meanwhile, methicillin-resistant Staphylococcus aureus (MRSA)
spread also in the community where highly virulent strains infect healthy adults that have no
predisposing risk factors. Although a few novel antibiotics have been recently introduced
into clinical practice, the search for alternative strategies to efficiently combat staphylococcal
infections is urgently demanded to decrease the enormous burden caused by pathogenic …